A Yeast‐Based Assay for Inhibitors of <scp>l</scp>‐Lactate Transport Utilizing Fluorescent Biosensors

Inhibitors of ʟ-lactate transport are in development as a novel mode of action in antitumor therapy and malaria. Previously, we used radiolabeled ʟ-lactate to assay transport via the human monocarboxylate transporter 1, MCT1, and the structurally unrelated malaria parasite's transporter, PfFNT. We encountered a sensitivity limit at IC<sub>50</sub> around 100 nM possibly resulting from the required high cell number per sample. Here, we describe a sensitive background-free high-throughput assay in yeast based on fluorescent iLACCO biosensors. We used iLACCO for co-expression and fusions with the transporter protein. Uptake of ʟ-lactate produced strong intensiometric fluorescent responses that could be monitored in cell suspensions using a fluorometer and in individual cells by fluorescence microscopy. The signal decreased dose-dependently in the presence of specific MCT1 and PfFNT inhibitors. Re-evaluation of 36 PfFNT inhibitors yielded IC<sub>50</sub> values below 100 nM now matching previous data on K<sub>i</sub> compound affinity to isolated transporter protein.

Authors

Institutions

Publication Details

Journal
ChemMedChem
Published
2024-12-13
DOI
https://doi.org/10.1002/cmdc.202400918
Citations
1
Primary Topic
Drug Transport and Resistance Mechanisms
Type
article
Field-Weighted Citation Impact
0.28

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A Yeast‐Based Assay for Inhibitors of l‐Lactate Transport Utilizing Fluorescent Biosensors

Eric Beitz, Manfred Menzel, Finn Tiedjens, Pauline Stahnke et al.
1 citations
ChemMedChem
Drug Transport and Resistance Mechanisms
0.28
article

A Yeast‐Based Assay for Inhibitors of l‐Lactate Transport Utilizing Fluorescent Biosensors

Eric Beitz, Manfred Menzel, Finn Tiedjens, Pauline Stahnke, Hanna Grotewold, Cane Uzun, Derya Yildirim
article en
1 citations

Abstract

Inhibitors of ʟ-lactate transport are in development as a novel mode of action in antitumor therapy and malaria. Previously, we used radiolabeled ʟ-lactate to assay transport via the human monocarboxylate transporter 1, MCT1, and the structurally unrelated malaria parasite's transporter, PfFNT. We encountered a sensitivity limit at IC<sub>50</sub> around 100 nM possibly resulting from the required high cell number per sample. Here, we describe a sensitive background-free high-throughput assay in yeast based on fluorescent iLACCO biosensors. We used iLACCO for co-expression and fusions with the transporter protein. Uptake of ʟ-lactate produced strong intensiometric fluorescent responses that could be monitored in cell suspensions using a fluorometer and in individual cells by fluorescence microscopy. The signal decreased dose-dependently in the presence of specific MCT1 and PfFNT inhibitors. Re-evaluation of 36 PfFNT inhibitors yielded IC<sub>50</sub> values below 100 nM now matching previous data on K<sub>i</sub> compound affinity to isolated transporter protein.

ChemMedChemVol. 20(7)
Christian-Albrechts-Universität zu Kiel (DE)
Deutsche Forschungsgemeinschaft
Good health and well-being
Openalex Percentile: Top 33%
Drug Transport and Resistance Mechanisms
0.28
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

A Yeast‐Based Assay for Inhibitors of <scp>l</scp>‐Lactate Transport Utilizing Fluorescent Biosensors — Eric Beitz, Manfred Menzel, et al. · ChemMedChem (2024) | TGRS Research Map | TGRS